Advances in new reversal agents will be key for managing patients treated with DOACs to prevent major bleeding events.
Benefits of protection with 2 doses administered over 1 month make the vaccine an important option for prevention of HBV.
With use of CD34+ cells via BB305 vector transduction, patients with severe β-thalassemia may no longer require long-term RBC transfusions as frequently or at all.
Increase in estimated population prevalence of elevated blood pressure from 11.8 to 14.2%.
In this meta-analysis of prospective population-based studies, sickle cell trait was not associated with any difference in risk of first ischemic stroke.
No moderate- or high-level evidence was found that SEP-1 or its hemodynamic interventions increase survival in septic adults.
A clinical prediction tool successfully forecasts subarachnoid hemorrhage management from ruptured intracranial aneurysms.
Increased frequency of television viewing may be linked to an increased risk for venous thromboembolism.
The addition of pharmacomechanical thrombolysis does not reduce the risk of post-thrombotic syndrome among patients with acute proximal deep vein thrombosis.
A 60-year-old man with a history of gastroesophageal reflux disease presents to the emergency department with 2 to 3 days of fever, non-bloody diarrhea, and a worsening non-pruritic rash.
New FDA-approved prophylactic treatment decreases bleeding episodes hemophilia A patients with factor VIII inhibitors.
An evaluation begins with a focused history and physical examination, CBC count with platelet trend, and examination of the peripheral smear.
Warfarin use may provide cancer protection across a broad range of malignant neoplasms.
In the 1 to 10 days after flu vaccine administration, there was no increased risk for VTE.
The researchers found that concurrent use of amiodarone, fluconazole, rifampin, and phenytoin was associated with increased risk of major bleeding compared with the use of NOACs alone.
VTE and cancer are the result of inflammation and immunological dysfunctions associated with RA.
A Divine guidance helps a nurse practitioner make a diagnosis that saved a patient's life.
A patient presents with chest pain 6 weeks after beginning use of a contraceptive device.
The updated guidelines will help clinicians prevent and manage nausea and vomiting caused by antineoplastic agents or radiation therapy in cancer patients.
Researchers found a paradoxical increase in thromboembolism risk in low-weight patients with atrial fibrillation and VTE who were treated with direct oral anticoagulants.
The universal vaccination against hepatitis B virus infection prevented non-Hodgkin lymphoma in adolescents.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Most routine coagulation tests can be reliably assessed in tubes stored for up to 8 hours.
Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.
A 53-year-old woman presents to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement.
The condition has one fundamental pathophysiology but multiple distinct clinical presentations, including venous and neurogenic.
Younger age, relapsing forms of MS, fewer prior immunotherapy treatments, and lower baseline EDSS score were factors associated with better outcomes for stem cell transplantation.
Rivaroxaban once daily and dabigatran twice daily showed evidence of lower thromboembolic rates.
The AABB evaluated studies that examined hemoglobin thresholds for red blood cell transfusion and red blood cell storage duration.
Activity trackers may help transfusion-dependent patients estimate hemoglobin levels.